Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Clinical trial NCT01857271 · TERMINATED

Trial details

NCT number: NCT01857271
Sponsor: Albert Einstein College of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer

Start date: 2013-11-01
Primary completion: 2017-08-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.